Kidney paired donation (KPD) is an important tool to facilitate living donor kidney transplantation (LDKT). Concerns remain over prolonged cold ischemia times (CIT) associated with shipping kidneys long distances through KPD. We examined the association between CIT and delayed graft function (DGF), allograft survival, and patient survival for 1267 shipped and 205 nonshipped/internal KPD LDKTs facilitated by the National Kidney Registry in the United States from 2008 to 2015, compared to 4800 unrelated, nonshipped, non-KPD LDKTs. Shipped KPD recipients had a median CIT of 9.3 hours (range = 0.25-23.9 hours), compared to 1.0 hour for internal KPD transplants and 0.93 hours for non-KPD LDKTs. Each hour of CIT was associated with a 5% increased odds of DGF (adjusted odds ratio: 1.05, 95% confidence interval [CI], 1.02-1.09, P < .01). However, there was not a significant association between CIT and allcause graft failure (adjusted hazard ratio [aHR]: 1.01, 95% CI: 0.98-1.04, P = .4), death-censored graft failure ( [aHR]: 1.02, 95% CI, 0.98-1.06, P = .4), or mortality (aHR 1.00, 95% CI, 0.96-1.04, P > .9). This study of KPD-facilitated LDKTs found no evidence that long CIT is a concern for reduced graft or patient survival. Studies with longer follow-up are needed to refine our understanding of the safety of shipping donor kidneys through KPD.
| BACKGROUND
Recent acceptance of the practice of KPD in the United States has given rise to national KPD registries that facilitate KPD exchanges between kidney donors and recipients separated by long distances.
1
Although these nationwide exchanges allow more incompatible pairs to participate in LDKT, the long distances between transplant centers result in prolonged cold ischemia time (CIT) for the shipped kidney.
The transplant community varies in whether they support shipping living donor kidneys long distances through KPD programs adding significant CIT. Some national programs, such as in Canada or The Netherlands, never ship extirpated living donor kidneys. 2, 3 On the other hand, the National Kidney Registry (NKR) in the United States has routinely shipped living donor kidneys since inception in 2008. 4 Our ability to evaluate and compare these different policies on shipping kidneys and establish an evidence-based, standard approach is limited by a paucity of research. Initial preliminary studies of shipped LDKT in KPD programs have suggested minimal to no association between CIT and graft or patient outcomes; however, these studies were limited by small sample sizes and minimal follow-up times. 5, 6 Additionally, none of these studies identified potential risk factors or predictors of poorer outcomes in shipped KPD kidneys with prolonged CIT. In a slightly different study population, a recent report of non-KPD LDKTs incurring longer CIT (maximum of 8 hours) in older donors (>50 years old) demonstrated poorer graft survival. 7 In larger studies of deceased donor organs, there has been conflicting evidence for the association between long CIT (upwards of 24 hours) and delayed graft function (DGF), poorer allograft survival, or poorer patient survival. 8, 9 In order to address the important clinical and programmatic questions about the benefits and risks of shipping KPD kidneys, this study compares a large cohort of KPD recipients facilitated by the NKR, a large national KPD exchange program, to a national cohort of unrelated LDKTs not shipped or facilitated in a KPD exchange, which was identified from the Scientific Registry of Transplant Recipients (SRTR). This study aims to identify associations between CIT and KPD recipient DGF, allograft failure, and patient death. Additionally, we sought to identify any associated risk factors for poorer outcomes. In comparison to data used in previous studies, the unique experience of the NKR offers a larger study population and longer CIT from transcontinental shipping.
| METHODS

| The National Kidney Registry
The NKR is a nonprofit, 501c organization comprising 76 transplant centers within the United States participating during this study period.
Details of the NKR have been previously described. 5 
| Study population
KPD transplants between February 1, 2008 and November 30, 2015 were identified from the NKR registry. The NKR registry was linked to the SRTR using the UNOS donor identifier to obtain demographic and clinical variables for the recipients and donors. Any transplant that could not be linked or validated on transplant center, transplant date, ABO, and gender was excluded from the study (5%, n = 78). Additionally, as a comparison group, we included the cohort of all living unrelated non-KPD transplants identified from the SRTR that had their transplant at an NKR-participating center, during the same time period, and with short CIT (<1.33 hours, the average CIT of in-center NKR exchanges). NKR exchanges where the kidney was shipped were termed "shipped exchange," NKR exchanges within the same center were termed "in-center exchanges," and the additional cohort of living unrelated non-KPD transplants from SRTR were termed "other nonexchange."
| Cold ischemia time
In this study, CIT was defined as the hours of cold ischemia time associated with facilitating the transplant. Three records of CIT >36 hours (exchange) and 2 records of CIT > 12 hours (in-center exchange) were
clinical research/practice, delayed graft function (DGF), donors and donation: paired exchange, graft survival, health services and outcomes research, kidney transplantation/nephrology recoded as unknown CIT as the prolonged CIT in these cases was likely due to confounding recipient factors.
| Delayed graft function
Delayed graft function (DGF) was ascertained through SRTR and defined as requiring dialysis in the first week after transplantation. We studied whether longer CIT was associated with increased odds of 
| All-cause graft failure
All-cause graft failure (ACGF) was ascertained through the SRTR.
Recipients were followed until graft failure, death, or administrative censorship on November 30, 2015. We studied whether longer CIT was associated with an increased hazard of ACGF. Adjusted ACGF estimates were based on a SRTR risk-adjustment approach.
Recipient factors included years of age at transplant, black race, peripheral vascular disease (PVD), DM, PRA at transplant, preemptive transplant, years of RRT, public insurance, highest education level, and year of transplant. Donor factors were adjusted for through LD KDPI.
| Death censored graft failure
Death censored graft failure (DCGF) was ascertained through SRTR.
Recipients were followed until graft failure, censorship for death, or administrative censorship on November 30, 2015. We studied whether longer CIT was associated with an increased hazard of DCGF, adjusting for the same recipient and donor factors as ACGF.
| Mortality
Mortality was ascertained through SRTR. Recipients were followed until death, or administrative censorship on November 30, 2015. We studied whether longer CIT was associated with an increased hazard of mortality. Adjusted mortality estimates were based on SRTR risk- 
| Donors older than 50
We investigated whether CIT was associated differently with DGF, ACGF, DCGF, and mortality based on whether the donor was 50 years of age or older. This was accomplished using an interaction term in the regression models of CIT and donor age >50 years of age described in the Statistical Analysis section below. This study used data from the SRTR. The SRTR data system includes data on all donor, wait-listed candidates, and transplant recipients in the United States, submitted by the members of the OPTN, and has been described elsewhere. 
| Data sources
| Statistical analysis
All analyses were conducted in Stata 14.2/MP for Linux (College Station, TX). For all analyses, P < .05 was considered statistically significant. Odds of DGF were estimated using a multilevel logistic regression that accounted for transplant center-level variation.
Hazard of graft failure and mortality was estimated with Cox regression models with shared frailty to account for center-level variation.
The shared frailty framework accounts for center-level variation in a manner similar to multilevel generalized linear regression models.
We used the log-likelihood ratio (LLR) test to test whether models fit with random-effects parameters (multilevel models) were better fit than regression models without these parameters. In this case, since the LLR compares the multilevel model with random effects to the single-level model, a LLR P < .05 implies that the association between CIT and posttransplant outcomes varies by center. In addition to these models, the hazard of ACGF, DCGF, and patient mortality stratified by type of LDKT (shipped exchange vs in-center exchange vs other nonexchange) were examined with Kaplan-Meier methods.
Multiple imputation by chained equations with 10 imputations over 100 iterations was used to handle missing covariates. Missing PRA categories were imputed as a nominal variable; missing CIT, BMI, and LD KDPI were linearly imputed. All methods of handling missing data were compared to case-wise deletion regression models. were transported via air and 206 (16%) via ground transportation.
| RESULTS
| Study population characteristics
The median shipping distance was 733 miles (1.5-2717-mile range). Figure 1 shows the geographic distribution of the 1267 shipped LDKTs in this sample, coded by shipped KPD with 0-10 (red) and >10 hours (blue) of CIT.
| Cold ischemia time
Shipped KPD recipients had a median (interquartile range) CIT of 9.3 Table 1 ).
The distribution of CIT is shown in Figure 2 separately for shipped KPD ( Figure 2A ) and in-center KPD and other nonexchange transplant ( Figure 2B ). CIT that were missing from SRTR were imputed using CIT reported to NKR in 53 cases. CIT remained missing in 30 (15%) incenter exchanges, in 21 (1.7%) of shipped exchanges, and none of the other nonexchanges. These remaining 51 cases with missing CIT were imputed statistically in each model in subsequent analyses.
| Delayed graft function
Shipped KPD recipients experienced 64 (5.1%) cases of DGF, in-center KPD experienced 7 (3.4%), and other non-KPD LDKT In an identically adjusted model where cases with missing data were handled by case-wise deletion (n = 5522), CIT remained associated with increased DGF (aOR 1.06; 95% CI, 1.02-1.09, P < .01).
| All-cause graft failure
One-year ACGF was 2.9% in shipped KPD, 1.1% in in-center KPD, and 2.5% in other non-KPD. Three-year ACGF was 7.0% in shipped KPD, (Table 3) . In an identically adjusted model where cases with missing data were handled by case-wise deletion (n = 5506), CIT was not associated with increased ACGF (aHR 1.02; 95% CI, 0.98-1.07, P = .3).
| Death-censored graft failure
One-year graft survival was 97.9% in shipped KPD, 99.0% in incenter KPD, and 98.7% in other non-KPD. Three-year graft survival All-cause graft failure was modeled in a Cox regression with shared frailties to adjust for center variation (n = 6272). Missing data were handled through multivariate imputation. aHR, adjusted hazard ratio; CI, confidence interval; KPD, kidney paired donation; LD KDPI, live donor kidney donor profile index; PRA, panel reactive antibodies; RRT, renal replacement therapy.
was 95.6% in shipped KPD, 97.0% in in-center KPD, and 96.4% in other non-KPD ( Figure 3B ). After accounting for heterogeneity between centers, recipient characteristics, and donor characteristics, there was no association found between CIT and death-censored graft failure (aHR 1.02, 95% CI, 0.98-1.06, P = .4). Recipient public health insurance, PRA 11-79, and LD KDPI were associated with increased hazard of DCGF. Recipient age, preemptive transplantation, and more recent year of transplant were associated with lower hazard of DCGF (Table 4) . In an identically adjusted model where cases with missing data were handled by case-wise deletion (n = 5506), CIT was not associated with increased DCGF (aHR 1.03; 95% CI, 0.99-1.05, P = .1).
| Mortality
One-year patient survival was 99.0% for shipped KPD, 100% for incenter KPD, and 98.7% for other non-KPD. Three-year patient survival was 97.2% for shipped KPD, 98.6% for in-center KPD, and 96.8% for (Table 5 ). In an identically adjusted model where cases with missing data were handled by case-wise deletion (n = 5506), CIT was not associated with increased mortality (aHR 1.05, 95% CI, 0.99-1.11, Death-censored graft failure was modeled in a Cox regression with shared frailties to adjust for center variation (n = 6272). Missing data were handled through multivariate imputation. aHR, adjusted hazard ratio; CI, confidence interval; KPD, kidney paired donation; LD KDPI, live donor kidney donor profile index; PRA, panel reactive antibodies; RRT, renal replacement therapy. Mortality was modeled in a Cox regression with shared frailties to adjust for center variation (n = 6272). Missing data were handled through multivariate imputation. aHR, adjusted hazard ratio; CI, confidence interval; KPD, kidney paired donation; LD KDPI, live donor kidney donor profile index; RRT, renal replacement therapy.
| Donors older than 50 years
There was no modified association between CIT and DGF among those with a donor aged >50 years (interaction P = .06). CIT remained associated with DGF among those with a donor aged 50 years or younger with aOR 1.07 (95% CI, 1.03-1.11, P < .001). There was no modified association between CIT and ACGF (P = .4), DCGF (P = .3), or mortality (P = .8) among those with older donors aged >50 years.
| DISCUSSION
The effect of shipping living donor kidneys on transplant recipient outcomes has been a major concern. In this retrospective cohort study Other large observational studies have found no significant associations between CIT and deceased donor allograft function. CIT of 4-8 hours was associated with an increased odds of deathcensored and all-cause graft failure. 7 We found no evidence that DGF, graft failure, or mortality differed by donors aged >50 years and those younger than age 50 years. These conflicting findings may be explained by differences in the study populations, study designs, and definitions of CIT used. In the Krishnan study, the kidneys were not shipped, and they excluded exchange transplants, transplants with CIT > 8 hours,
and ABO-incompatible transplants. Although that study had longer follow-up (median 6.6 years), their maximum CIT was only 8 hours, less than the median CIT of 9 hours and a maximum of 23.9 hours in this study. Other previous studies of living donor exchange programs and shipping kidneys in the United States were limited by small sample sizes and shorter CIT, but report findings similar to what this study reports in regard to DGF and graft and patient outcomes. 5, 6 Aside from CIT, previous studies investigating outcomes of LDKT found risk factors that were similar to our results for DGF, allograft, and patient survival. [16] [17] [18] Routine use of older living donors is increasing in clinical practice, and organs from older donors have been repeatedly shown to have worse outcomes in LDKT but remain comparatively better than standard, young deceased donor organs. 19 In particular, DGF rates above 5% are seen with donors above the age of 60 years, which is well above the recent overall DGF rate of 2.75% for LDKT reported in the SRTR Annual Report. 20 On the other hand, higher donor age, which independently predicted poorer graft survival in this study, suggests that prolonged CIT may prove less harmful than other factors (such as age). Considering these and other acceptable risk factors for poorer outcomes in LDKT, distance between centers, shipping, and potentially prolonged cold storage can be a consideration in optimizing strategies for matching for exchange outcomes. However, this study does not suggest that long shipping times should prevent exchanges from occurring or contribute to the barriers to transplantation.
The results of this study need to be considered in the context of study design. The primary limitation of the study is its limited follow-up time, with a maximum of 7.8 years. Ultimately, longterm graft survival after shipped KPD entailing long CIT must be investigated, and continued follow-up of the participants in this study is an important next step. Next, retrospective studies like this one are limited by unmeasured confounding variables.
While attempts were made to account for other transplant center, recipient, and donor factors that may be associated with posttransplant outcomes, there are other unique unmeasured/unrecognized variables in exchange programs that potentially alter graft and patient outcomes. These include variables such as improved HLA-matching, use of alternate, potentially less aggressive desensitization protocols, and garnering more "high profile" attention as exchange cases in transplant centers. Unmeasured variations between shipping protocols and in-center exchanges also could contribute to the differences in outcomes. These would include differences in packing and handling the organs, variations in operative techniques (donor and recipient), and unfamiliar donor and recipient surgeons working together in out-of-center exchanges.
Furthermore, recipients in exchange programs tend to be more complex immunologically (sensitized), have donor-specific antibodies, have undergone prior transplantation, or have other extenuating circumstances surrounding their operative procedure.
Together, these unmeasured factors could be confounding the outcomes we studied in shipped KPDs. A third limitation of using large administrative databases is with missing data. Additionally, the impact of pumping the organ during transport could not be studied here. In this study, CIT was missing in 51 cases from both 
